Apsen Farmaceutica S/A
R. Barao do Rio Branco, 835 - Santo Amaro,
Sao Paulo, 04753-001,
Brazil
Sao Paulo, 04753-001,
Brazil
55 11 5645-5011
Life Sciences
Apsen Farmaceutica S/A Technographics
Apsen Farmaceutica S/A Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Apsen Farmaceutica S/A and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 1500 Apsen Farmaceutica S/A employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Apsen Farmaceutica S/A has purchased the following applications: Linx Humanus for Core HR in 2017, Microsoft 365 for Collaboration in 2015, Exclaimer Cloud Signatures for Office 365 for Digital Signing in 2017 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Apsen Farmaceutica S/A is running and its propensity to invest more and deepen its relationship with Linx , SAP , Microsoft or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Apsen Farmaceutica S/A revenues, which have grown to $220.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Apsen Farmaceutica S/A intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Apsen Farmaceutica S/A Tech Stack and Enterprise Applications
Apsen Farmaceutica S/A HCM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Linx | Legacy | Linx Humanus | Core HR | HCM | n/a | 2017 | 2018 |
In 2017, Apsen Farmaceutica S/A implemented Linx Humanus in its Core HR environment. The company selected Humanus, a provider specialized in Consulting and Systems for Human Capital Management, based on its suitability as a more current and complete system compatible with SAP.
The Linx Humanus deployment centered on payroll and benefits management, delivering configured payroll processing that supports payments of variable amounts and specific calculations required by distinct collective agreements. The implementation included registration and administration of all employee benefits and the ability to issue multiple operational and compliance reports, meeting stated company particularities.
Integration work established a direct interface with the SAP system, enabling data exchange between Linx Humanus and SAP to support payroll and benefits data flows. The architecture emphasized application compatibility with SAP and HCM functional workflows, aligning Core HR processes with broader financial and ERP controls.
Operational ownership resided with HR and payroll functions, with system configuration tailored to company specificities such as variable pay rules and collective agreement logic. Linx Humanus was positioned to centralize reporting and benefits control while interfacing with SAP, addressing the implementation goals articulated by Apsen Farmaceutica S/A.
|
|
|
|
|
Recruiting, Applicant Tracking System | HCM |
|
2016 | 2016 |
|
Apsen Farmaceutica S/A Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2015 | 2015 |
In 2015, Apsen Farmaceutica S/A implemented Microsoft 365 as its Collaboration platform. The company references Microsoft 365 on its public website, indicating the cloud suite forms part of its corporate productivity and collaboration footprint.
The implementation centers on Microsoft 365 capabilities such as Exchange Online for enterprise email and calendaring, SharePoint Online for intranet and document management, OneDrive for personal file sync, Microsoft Teams for real time chat and meetings, and the Office desktop and web applications for content creation. Microsoft 365 is used to support standard collaboration workflows, content lifecycle management, and synchronous and asynchronous team communication across the business.
The deployment follows a cloud tenant oriented architecture managed by corporate IT, delivering Collaboration services to commercial, corporate support, and operations functions within the Brazil organization. Configuration emphasis is on centralized account provisioning, role based access controls, and tenant level policy enforcement consistent with Microsoft 365 administration patterns.
Governance and operational controls are described in terms of policy driven provisioning, retention and secure sharing rules, and mobile and remote access management, reflecting typical Collaboration governance for regulated life sciences environments. The narrative on the public site confirms Microsoft 365 is an embedded part of Apsen Farmaceutica S/A application stack for enterprise collaboration.
|
|
|
|
|
Collaboration | Collaboration |
|
2021 | 2021 |
|
Apsen Farmaceutica S/A Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Exclaimer | Legacy | Exclaimer Cloud Signatures for Office 365 | Digital Signing | Content Management | n/a | 2017 | 2017 |
In 2017, Apsen Farmaceutica S/A implemented Exclaimer Cloud Signatures for Office 365. The deployment uses Exclaimer Cloud Signatures for Office 365 to centralize email signature management and is visible on the company website, positioning the solution within the company Digital Signing footprint. The architecture is cloud-hosted and integrated with Office 365 mail flow so signatures can be applied at the server level independent of user endpoints.
Configuration focuses on template-driven HTML signatures, centralized administration for corporate communications and compliance, and directory-driven personalization using Office 365 user attributes, reflecting standard capabilities of Digital Signing solutions. Governance was oriented to centralized template control and approval workflows to coordinate marketing and legal oversight, while template orchestration and policy enforcement are managed within Exclaimer Cloud Signatures for Office 365.
|
|
|
|
|
Digital Signing | Content Management |
|
2021 | 2021 |
|
Apsen Farmaceutica S/A CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Marketing Automation | CRM |
|
2020 | 2020 |
|
Apsen Farmaceutica S/A TRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Governance, Risk and Compliance | TRM |
|
2021 | 2021 |
|
|
|
|
|
Governance, Risk and Compliance | TRM |
|
2021 | 2021 |
|
Apsen Farmaceutica S/A IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2014 | 2014 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2020 | 2020 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2020 | 2020 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2020 | 2020 |
|
Apsen Farmaceutica S/A CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Secure Email Gateways (SEGs) | CyberSecurity |
|
2017 | 2017 |
|
IT Decision Makers and Key Stakeholders at Apsen Farmaceutica S/A
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Apsen Farmaceutica S/A Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Apsen Farmaceutica S/A IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Apsen Farmaceutica S/A digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Apsen Farmaceutica S/A Technographics
Apsen Farmaceutica S/A is a Life Sciences organization based in Brazil,
with around 1500 employees and annual revenues of $220.0 million.
Apsen Farmaceutica S/A operates a diverse technology stack with applications such as
Linx Humanus, Microsoft 365 and Exclaimer Cloud Signatures for Office 365,
covering areas like Core HR, Collaboration and Digital Signing.
Apsen Farmaceutica S/A has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as Linx, Microsoft and Exclaimer.
Apsen Farmaceutica S/A recently adopted applications including
CodeTwo Email Signatures in 2021, DocuSign eSignature in 2021 and OneTrust Cookie Consent in 2021,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Apsen Farmaceutica S/A’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Apsen Farmaceutica S/A’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Apsen Farmaceutica S/A technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.